Ondine Biomedical
Ondine Biomedical is a Canadian company specializing in photodisinfection-based therapies to combat infections, including those resistant to drugs, with its notable product, Steriwave, aimed at rapid nasal decolonization.
Services
Ondine Biomedical specializes in photodisinfection-based therapies designed to prevent and treat a wide range of infections, including those caused by drug-resistant pathogens. Their technology uses light to destroy bacteria, viruses, yeasts, and fungi without causing antimicrobial resistance. Key services include the rapid nasal decolonization therapy known as Steriwave, which targets pathogens in the nose swiftly and effectively.
Products
Ondine Biomedical offers Steriwave, a rapid nasal decolonization therapy that eradicates a broad spectrum of pathogens in minutes. The company is also developing products aimed at chronic rhinosinusitis, the decolonization of burns and wounds, and the disinfection of endotracheal tubes to reduce the incidence of ventilator-associated pneumonia. It's important to note that these products are not currently for sale in the U.S.
History
Ondine Biomedical has demonstrated significant impacts in infection prevention and treatment, particularly in Canadian hospitals, where they have achieved up to an 84% reduction in postoperative infection rates with their Steriwave therapy. The company is headquartered in Vancouver, Canada, and maintains research and development facilities in Bothell, WA, USA.
Research and Development
Ondine Biomedical operates research and development facilities in Bothell, WA, USA. Their R&D efforts are focused on advancing photodisinfection technology and developing new applications for the prevention and treatment of infections. Current projects include therapies for chronic rhinosinusitis, the decolonization of burns and wounds, and strategies to reduce ventilator-associated pneumonia through the disinfection of endotracheal tubes.